Viewing Study NCT06199232


Ignite Creation Date: 2025-12-24 @ 9:48 PM
Ignite Modification Date: 2025-12-25 @ 7:27 PM
Study NCT ID: NCT06199232
Status: RECRUITING
Last Update Posted: 2024-12-04
First Post: 2023-12-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed from Standard Systemic Treatment
Sponsor: Peking University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module